Latest Articles

Publication Date
Study Finds GLP-1 Medications Combined with Progestin Therapy May Lower Endometrial Cancer Risk - geneonline.com

Study Finds GLP-1 Medications Combined with Progestin Therapy May Lower Endometrial Cancer Risk geneonline.com

Published: Feb. 16, 2026, 6:10 a.m.
Study Finds GLP-1 Agonists Combined with Progestin Reduce Endometrial Cancer Risk by 66% - geneonline.com

Study Finds GLP-1 Agonists Combined with Progestin Reduce Endometrial Cancer Risk by 66% geneonline.com

Published: Feb. 16, 2026, 5:37 a.m.
Adnexectomy at Vaginal Hysterectomy for Benign Non-prolapse Indications: A National NSQIP Analysis of Practice Patterns and Perioperative Outcomes.

Professional societies recommend opportunistic salpingectomy during vaginal hysterectomy to reduce the risk of ovarian cancer, but it may be technically challenging without uterine prolapse. We examined national patterns, patient and …

Published: Feb. 15, 2026, midnight
Combining GLP-1 drugs with hormones may lower uterine cancer risk - Medical Xpress

Combining GLP-1 drugs with hormones may lower uterine cancer risk Medical Xpress

Published: Feb. 14, 2026, 4 p.m.
Women’s Cancer Risk Is Rising: How Obesity and Hormones Are Fueling the Crisis - Times Now

Women’s Cancer Risk Is Rising: How Obesity and Hormones Are Fueling the Crisis Times Now

Published: Feb. 14, 2026, 7:28 a.m.
GLP-1 Combination Reduced Endometrial Cancer Risk by 66%, Study Finds - Pharmacy Times

GLP-1 Combination Reduced Endometrial Cancer Risk by 66%, Study Finds Pharmacy Times

Published: Feb. 13, 2026, 5:09 p.m.
Systematic Review of the Lived Experiences of Women Participating in Therapeutic Yoga.

No study has synthesized qualitative insights related to yoga across various women's health concerns, including breast and ovarian cancer, endometriosis, menopause, and pregnancy, despite numerous individual studies. The present review …

Published: Feb. 13, 2026, midnight
Genetic risk may rival obesity as a key driver of endometrial cancer - Medical Xpress

Genetic risk may rival obesity as a key driver of endometrial cancer Medical Xpress

Published: Feb. 12, 2026, 8:16 p.m.
How Should Inoperable Endometrial Cancer be Treated? - CancerNetwork

How Should Inoperable Endometrial Cancer be Treated? CancerNetwork

Published: Feb. 12, 2026, 4:05 p.m.
Totus Medicines to Present Updated Phase 1 Clinical Data for TOS-358 at ESMO Targeted Anticancer Therapies Congress 2026 - The Manila Times

Totus Medicines to Present Updated Phase 1 Clinical Data for TOS-358 at ESMO Targeted Anticancer Therapies Congress 2026 The Manila Times

Published: Feb. 12, 2026, 1:07 p.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!